Present-day trends in treatment of bacterial vaginosis

Efficacy of Clindamycin Vaginal Ovule (3-Day Treatment) vs. Clindamycin Vaginal Cream (7-Day Treatment) in Bacterial Vaginosis

OBJECTIVE To compare the efficacy and safety of a 3-day regimen of clindamycin vaginal ovules with a 7-day regimen of clindamycin vaginal cream for the treatment of bacterial vaginosis (BV). METHODS Women with a clinical diagnosis of BV were treated with a 3-day course of clindamycin ovules or a 7-day course of clindamycin cream administered intravaginally. Three hundred and eighty-four patie...

Local treatment for bacterial vaginosis.

Bacterial vaginosis (non-specific vaginitis) is a mild but common condition. O'Dowd et al reported that organisms associated with vaginosis could be isolated from 37% of women who presented with vaginal symptoms. The current treatment of choice is an oral nitroimidazole (metronidazole or tinidazole), given either as a single large dose or as a twice daily regimen for five to seven days. A probl...

Tinidazole in the treatment of bacterial vaginosis

Bacterial vaginosis (BV) is the commonest cause of vaginal discharge in women of childbearing age. Oral metronidazole has long been established as an effective therapy in the treatment of BV. However, adverse effects due to metronidazole are frequent and this may lead to problems with adherence to a 7-day course of treatment and subsequently result in treatment failure. Oral tinidazole has been...

The Present Day Treatment

In the last three or four years the treatment of diabetes has been greatly simplified, and the introduction of insulin has enabled the general practitioner to treat diabetes with a considerable degree of success. Yet there still appears to exist some confusion as to the indications and contraindications for certain well established therapeutic measures in the management of diabetes. It is the p...

Bacterial Vaginosis: Update on Pathogenesis and Treatment